Skip to main content

Bristlecone Advisors, LLC

SEC CIK
0001671716
Latest filing
Oct 24, 2025

IBRX holding history

ImmunityBio, Inc. in every 13F filed by Bristlecone Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

IBRX overviewAll 13F holders of IBRXFull Q3 2025 holdings

Shares (Q3 2025)
0
Sold out in Q3 2025
Value
$0
% of portfolio
0.0%
Quarters held
2
Since Q1 2025
Holdings of IBRX by Bristlecone Advisors, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q3 20250$00.0%−36,000−100.0%Sold outHolders
Q2 202536,000$95.0K<0.1%00.0%UnchangedHolders
Q1 202536,000$108.4K<0.1%+36,000NewHolders